These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9779990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL, Heath AW, Pelech SL, Young PR, Gold MR.
    J Immunol; 1996 Oct 15; 157(8):3381-90. PubMed ID: 8871635
    [Abstract] [Full Text] [Related]

  • 6. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
    Salmeron A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP, Ley SC.
    EMBO J; 1996 Feb 15; 15(4):817-26. PubMed ID: 8631303
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses.
    Moriguchi T, Toyoshima F, Masuyama N, Hanafusa H, Gotoh Y, Nishida E.
    EMBO J; 1997 Dec 01; 16(23):7045-53. PubMed ID: 9384583
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structural analysis of the MAP kinase ERK2 and studies of MAP kinase regulatory pathways.
    Cobb MH, Xu S, Cheng M, Ebert D, Robbins D, Goldsmith E, Robinson M.
    Adv Pharmacol; 1996 Dec 01; 36():49-65. PubMed ID: 8783554
    [No Abstract] [Full Text] [Related]

  • 17. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1.
    Ward Y, Gupta S, Jensen P, Wartmann M, Davis RJ, Kelly K.
    Nature; 1994 Feb 17; 367(6464):651-4. PubMed ID: 8107850
    [Abstract] [Full Text] [Related]

  • 18. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.
    Waskiewicz AJ, Flynn A, Proud CG, Cooper JA.
    EMBO J; 1997 Apr 15; 16(8):1909-20. PubMed ID: 9155017
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.
    Bardwell AJ, Abdollahi M, Bardwell L.
    Biochem J; 2004 Mar 01; 378(Pt 2):569-77. PubMed ID: 14616089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.